sion of CD30 by human CD4＋ T cells producing Th2-type cytokines.FASEB J,19 95,9:81-86. 8，
del Prete G,de Carli M,D′Elios MM,et al.CD30-mediated signa ling promotes the development of human T helper type 2-like T cells.J Exp Med,1 995,182:1655-1661. 9，Hagiwara E,Gourley MF,Lee S,et al.Disease severity in patient s with systemic lupus erythematosus correlates with an increased ratio of interl eukin-10:interferon-γ-secreting cells in the peripheral blood.Arthritis Rheu m,1996,39:379-385.
10，Richand PY,Alcocer VJ,Llorente L.High levels of Th2 cytokine gene exp ression in systemic lupus erythematosus.Rev Invest Clin,1995,47:267-272.
11，Kitani A,Hara M,Hirose T,et al.Heterogeneity of B cell responsiveness to interleukin 4,interleukin 6 and low molecular weight B cell growth factor in discrete stages of B cell activation in patients with systemic lupus erythemato sus.Clin Exp Immunol,1989,77:31-36.
12，Caligaris-Cappio F,Bertero MT,Converso M,et al.Circulating levels of soluble CD30:a marker of cells producing Th2-type cytokines,are increased in p atients with systemic lupus erythematosus and correlate with disease activity.Cl in Exp Rheum,1995,13:339-343.
13，Spinozzi F,Agea E,Piattoni S,et al.Lack of correlation between membra ne CD30 expression and cytokine secretion pattern in allergen-primed naive cord blood T cell lines and clones.Scand J Immunol,19
97,45:417-422.
上一页 [1] [2] [3]
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文